当前位置:产品中心>单抗/多抗

Anti-Human ADAM9 Reference Antibody|抗人ADAM9参考抗体(靶标:人解整合素-金属蛋白酶9)

货号:RB9T37016192
  • 价格:面议
  • 点击数:519
  

产品介绍

产品参数

形态Liquid
宿主种属Human
克隆性Monoclonal
抗体亚型IgG1-kappa
纯度>95% purity as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
浓度1mg/ml
内毒素水平Please contact the lab for this information.
应用ELISA, Bioactivity: FACS, Functional assay, Research in vivo
种属反应性Human
靶标Disintegrin and metalloproteinase domain-containing protein 9, Meltrin-gamma, ADAM9, MDC9, MLTNG, ADAM 9, Metalloprotease/disintegrin/cysteine-rich protein 9, Cellular disintegrin-related protein, KIA
储存缓冲液0.01M PBS, pH 7.4.
稳定性和储存Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
表达系统Mammalian Cells
登录号Q13443
背景信息Izeltabart is a high-affinity humanized antibody targeting ADAM9. Izeltabart can be used as ADC Antibody for site-specific conjugation with Maytansinoid-based DM21-C (a Drug-Linker Conjugates for ADC), to synthesize IMGC936 (Antibody-Drug Conjugates (ADCs)) with strong anti-cancer activity. DM21-C is composed of Maytansinoid (microtubule inhibitor) and a stable tripeptide linker. IMGC936 exhibits cytotoxicity against ADAM9-positive human tumor cell lines and potent antitumor activity in xenograft tumor models.<br>
别名2642078-60-0
备注For research use only. Not suitable for clinical or therapeutic use.